These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10176482)

  • 1. Buddy up with a lawyer, it's compliance program time.
    Pontius CA
    MLO Med Lab Obs; 1998 Jan; 30(1):21, 23. PubMed ID: 10176482
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent trends in physician practice acquisitions: a focus on value and compliance.
    Blair LS; Hahn AD; Sarra JB
    Health Care Law Mon; 1998 Aug; ():21-7. PubMed ID: 10186117
    [No Abstract]   [Full Text] [Related]  

  • 3. Solicitation of new safe harbors and special fraud alerts--OIG, HHS. Notice of intent to develop regulations.
    Fed Regist; 1998 Dec; 63(237):68223-4. PubMed ID: 10338886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buyer beware: complying with amended stark and anti-kickback regulations.
    Klein SR; Fox SJ
    J Healthc Inf Manag; 2008; 22(2):8-10. PubMed ID: 19266987
    [No Abstract]   [Full Text] [Related]  

  • 5. White coat warriors: capitation and compliance send labs into a battle for survival.
    Marietti C
    Healthc Inform; 1999 Jun; 16(6):43-4, 46-9. PubMed ID: 10557641
    [No Abstract]   [Full Text] [Related]  

  • 6. Protecting the Medicare trust fund.
    Optometry; 2011 Apr; 82(4):256-8. PubMed ID: 21563352
    [No Abstract]   [Full Text] [Related]  

  • 7. Incorporating compliance into your practice: a primer on the fraud and abuse laws.
    Shuren AW
    J Pediatr Health Care; 2001; 15(3):151-4. PubMed ID: 11353367
    [No Abstract]   [Full Text] [Related]  

  • 8. The attorney/client privilege: a fond memory of things past an analysis of the privilege following United States v. Anderson.
    Mustokoff MM; Swichar JL; Herzfeld CR
    Ann Health Law; 2000; 9():107-24, inside cover. PubMed ID: 11430217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Publication of OIG compliance program guidance for clinical laboratories--HHS. Notice.
    Fed Regist; 1998 Aug; 63(163):45076-87. PubMed ID: 10182693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It's OK to ignore referral bans in certain cases, HCFA indicates.
    Caesar N
    Manag Care; 1999 Feb; 8(2):55-6. PubMed ID: 10346111
    [No Abstract]   [Full Text] [Related]  

  • 11. How to defuse compliance time bombs. Six hypothetical allegations. Panel discussion.
    Frogale C; McAdams R; Raspanti M; Ward R
    MLO Med Lab Obs; 1999 May; 31(5):20-2, 24-6, 28-31. PubMed ID: 10537418
    [No Abstract]   [Full Text] [Related]  

  • 12. Healthcare compliance update.
    Englander J
    NAHAM Manage J; 1998; 24(5):3-5. PubMed ID: 10387354
    [No Abstract]   [Full Text] [Related]  

  • 13. Complex regulations are driving hospitals' corporate compliance efforts.
    Campbell S
    Health Care Strateg Manage; 1998 Apr; 16(4):17. PubMed ID: 10178054
    [No Abstract]   [Full Text] [Related]  

  • 14. Learning the laws behind compliance.
    Wagg DG
    J AHIMA; 2000 May; 71(5):20-1. PubMed ID: 11009869
    [No Abstract]   [Full Text] [Related]  

  • 15. Stark III: refinement not revolution (part 1).
    Gosfield AG
    Fam Pract Manag; 2008 Mar; 15(3):25-8. PubMed ID: 18422263
    [No Abstract]   [Full Text] [Related]  

  • 16. Avoiding fraud and abuse: five rules for success.
    Caesar N
    Manag Care; 1995 May; 4(5):53-4. PubMed ID: 10142988
    [No Abstract]   [Full Text] [Related]  

  • 17. Compliance programs: serious business for health care providers.
    Chananie SJ; Gulick SL
    J Am Coll Radiol; 2007 Apr; 4(4):214-6. PubMed ID: 17412270
    [No Abstract]   [Full Text] [Related]  

  • 18. Complying with physician gain-sharing restrictions.
    O'Hare PK
    Healthc Financ Manage; 1998 May; 52(5):36-7. PubMed ID: 10179436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a corporate compliance program to combat fraud.
    Dombi WA
    Caring; 1996 Feb; 15(2):48-51. PubMed ID: 10156984
    [No Abstract]   [Full Text] [Related]  

  • 20. Corporate compliance and integrity programs: the uneasy alliance between law and ethics.
    Guinn DE
    HEC Forum; 2000 Dec; 12(4):292-302. PubMed ID: 11138248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.